KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Amortization - Intangibles (2019 - 2025)

Pacira BioSciences has reported Amortization - Intangibles over the past 7 years, most recently at $14.3 million for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $14.3 million for Q4 2025, changed 0.24% from a year ago — trailing twelve months through Dec 2025 was $57.3 million (changed 0.02% YoY), and the annual figure for FY2025 was $57.3 million, changed 0.0%.
  • Amortization - Intangibles for Q4 2025 was $14.3 million at Pacira BioSciences, roughly flat from $14.3 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for PCRX hit a ceiling of $14.3 million in Q2 2022 and a floor of $2.0 million in Q2 2021.
  • Median Amortization - Intangibles over the past 5 years was $14.3 million (2022), compared with a mean of $12.1 million.
  • Biggest five-year swings in Amortization - Intangibles: dropped 1.65% in 2021 and later surged 628.11% in 2022.
  • Pacira BioSciences' Amortization - Intangibles stood at $7.7 million in 2021, then surged by 87.14% to $14.3 million in 2022, then changed by 0.0% to $14.3 million in 2023, then decreased by 0.24% to $14.3 million in 2024, then increased by 0.24% to $14.3 million in 2025.
  • The last three reported values for Amortization - Intangibles were $14.3 million (Q4 2025), $14.3 million (Q3 2025), and $14.3 million (Q2 2025) per Business Quant data.